5-Keto-2,2,6,6-tetramethylheptansaeure

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 5-Keto-2,2,6,6-tetramethylheptansaeure
• 英文别名: 2,2,6,6-Tetramethyl-5-oxoheptanoic acid
• 化学式: C₁₁H₂₀O₃
• 分子量: 200.278
• InChiKey: PUGXIQWESNPGOI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-diazo-2,2,6,6-tetramethylheptane-3,5-dione 在 水 作用下， 以 四氢呋喃 为溶剂， 生成 5-Keto-2,2,6,6-tetramethylheptansaeure
  参考文献：
  名称：

  Nikolaev,V.A. et al., Journal of Organic Chemistry USSR (English Translation), 1978, vol. 14, p. 1338 - 1346

  摘要：

  DOI：

文献信息

• PYRROLE COMPOUNDS AS GRANZYME B INHIBITORS
  申请人：viDA Therapeutics Inc.

  公开号：US20170015705A1

  公开（公告）日：2017-01-19

  Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
• PROLINE COMPOUNDS AS GRANZYME B INHIBITORS
  申请人：viDA Therapeutics Inc.

  公开号：US20170015706A1

  公开（公告）日：2017-01-19

  Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
• COVALENT GRANZYME B INHIBITORS
  申请人：viDA Therapeutics Inc.

  公开号：US20170015707A1

  公开（公告）日：2017-01-19

  Covalent Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. A method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
• AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
  申请人：viDA Therapeutics Inc.

  公开号：US20170218014A1

  公开（公告）日：2017-08-03

  Azaindoline compounds as granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
• US9458193B1
  申请人：——

  公开号：US9458193B1

  公开（公告）日：2016-10-04